# Sinetrol (Citrus sinensis/Citrus paradisi extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sinetrol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Sinetrol-XPur, Mediterranean citrus extract, Citrus sinensis extract, Citrus paradisi extract, Polyphenol citrus complex, Sweet orange-grapefruit extract, Mediterranean weight-loss formula, Citrus polyphenol extract

## Overview

Sinetrol is a patented citrus polyphenol extract derived from Citrus sinensis and Citrus paradisi, standardized for naringenin, hesperidin, neohesperidin, and caffeine. Its primary mechanism involves inhibition of phosphodiesterase-3 (PDE-3), which elevates intracellular cAMP and drives lipolysis in adipose tissue.

## Health Benefits

• Reduces body fat mass while preserving lean muscle mass (clinical trials on Asian and Caucasian subjects)
• Decreases waist and hip circumference measurements (2015 French trial with 630 mg/day Sinetrol-XPur)
• Enhances lipolysis by 2.8-fold through PDE-3 inhibition (Dallas et al., Phytomedicine 2008, p<0.05)
• Promotes adipose tissue beiging to increase resting energy expenditure (mechanism studies)
• Provides non-thermogenic weight management without stimulant effects (100% weight loss from fat mass vs placebo)

## Mechanism of Action

Sinetrol inhibits phosphodiesterase-3 (PDE-3) in adipocytes, preventing the degradation of cyclic AMP (cAMP) and thereby sustaining protein kinase A (PKA) activation, which phosphorylates hormone-sensitive lipase (HSL) to mobilize stored triglycerides. This cascade produces a 2.8-fold increase in lipolytic activity compared to control, as measured by glycerol release in isolated adipocytes (Dallas et al., Phytomedicine 2008). The polyphenols naringenin and hesperidin are considered the primary bioactive drivers of PDE inhibition, while the naturally present caffeine may contribute synergistically through adenosine receptor antagonism.

## Clinical Summary

A 2015 randomized, double-blind, placebo-controlled French trial (n=95 overweight adults) using 630 mg/day Sinetrol-XPur for 12 weeks demonstrated significant reductions in body fat mass, waist circumference, and hip circumference versus placebo. Separate trials enrolling both Asian and Caucasian cohorts confirmed reductions in total body fat percentage while lean muscle mass was preserved, suggesting a selective lipolytic action without catabolism. Dallas et al. (2008, Phytomedicine) documented the 2.8-fold lipolysis enhancement in vitro and supported the PDE-3 mechanism. Overall evidence quality is moderate—trials are industry-sponsored, relatively short in duration, and use small-to-medium sample sizes, warranting independent replication.

## Nutritional Profile

Sinetrol is a standardized polyphenol-rich extract derived from sweet orange (Citrus sinensis) and grapefruit (Citrus paradisi) pulp, not a whole food ingredient, so macronutrient content is negligible at functional doses. Bioactive composition is characterized primarily by flavanones and flavones: naringin (from grapefruit, typically 15–30% of extract by weight), hesperidin (from sweet orange, typically 10–25%), neohesperidin, narirutin, and didymin. The XPur commercial form is standardized to ≥60% total polyphenols by dry weight. Also contains hydroxycinnamic acids including caffeic acid and p-coumaric acid at minor concentrations (<5%). Carotenoids (beta-cryptoxanthin, zeaxanthin) are present in trace amounts from the fruit pulp matrix. Vitamin C content is negligible after extraction processing. No meaningful protein, fat, or dietary fiber content at the 300–630 mg/day functional dose range used in clinical trials. Bioavailability: Flavanones undergo hydrolysis by colonic microbiota to yield aglycone forms (naringenin, hesperetin), which are the primary absorbed species; peak plasma concentrations of naringenin reach approximately 0.5–1.5 µmol/L following typical doses. The polyphenol matrix exhibits synergistic PDE-3 inhibitory activity not attributable to single isolated compounds, indicating bioactivity is concentration- and matrix-dependent.

## Dosage & Preparation

Clinically studied dosage: 630 mg/day of Sinetrol-Xpur C, taken as either 2x450 mg/day capsules or 1x900 mg/day tablets. Standardization includes >40% flavanones (naringin, hesperidin) and 3.5% caffeine. Some formulations contain 60% total polyphenols, 16.7% flavanones, 2% anthocyanins, and 3.6% caffeine. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Sinetrol is generally well tolerated at studied doses (630–900 mg/day), with no serious adverse events reported in published clinical trials lasting up to 12 weeks. Because it contains naturally occurring caffeine, individuals sensitive to stimulants may experience mild [insomnia](/ingredients/condition/sleep), increased heart rate, or jitteriness, particularly when combined with other caffeine-containing products. Naringenin, a key constituent, is a known inhibitor of cytochrome P450 enzymes CYP3A4 and CYP1A2, which could theoretically raise plasma levels of medications metabolized by these pathways, including statins, calcium channel blockers, and certain immunosuppressants—similar to grapefruit drug interactions. Safety data in pregnant or breastfeeding women and in pediatric populations is absent, and use in these groups should be avoided until evidence is available.

## Scientific Research

Clinical evidence includes the Dallas et al. (Phytomedicine 2008) study demonstrating potent lipolytic activity via 97% PDE inhibition and 2.8-fold increase in free fatty acid release. A 2015 French human trial on Sinetrol-XPur (630 mg/day) reported significant abdominal fat, waist, and hip reductions in men, though specific PMIDs for direct Sinetrol RCTs were not provided in available data. Fytexia cites trials showing 100% weight loss from fat mass using 2x450 mg/day protocols with Harris-Benedict individualized intakes.

## Historical & Cultural Context

No historical or traditional medicinal uses are documented for Sinetrol, as it is a modern patented ingredient explicitly designed as a 'unique Mediterranean weight-loss' formula. The product was inspired by the polyphenol-rich Mediterranean diet rather than any specific traditional medicine system.

## Synergistic Combinations

Green tea extract, L-carnitine, conjugated linoleic acid (CLA), chromium picolinate, forskolin

## Frequently Asked Questions

### What is the effective dose of Sinetrol for fat loss?

Clinical trials have used doses of 630 mg/day (Sinetrol-XPur formulation) in 12-week interventions and demonstrated statistically significant reductions in body fat and waist circumference. Some protocols use up to 900 mg/day split across two doses with meals. No dose-response data beyond this range has been published, so exceeding 900 mg/day is not evidence-supported.

### How long does Sinetrol take to work?

The primary clinical trial showing waist and hip circumference reductions ran for 12 weeks, suggesting meaningful body composition changes require at least 8–12 weeks of consistent daily use. Early mechanistic changes at the cellular level—elevated cAMP and HSL phosphorylation—occur acutely, but measurable anthropometric outcomes accumulate over weeks. No published data supports clinically significant fat loss in periods shorter than 8 weeks at studied doses.

### Can Sinetrol interact with grapefruit-sensitive medications?

Yes, this is a clinically relevant concern because Sinetrol contains naringenin, the same flavanone responsible for grapefruit-drug interactions. Naringenin inhibits intestinal and hepatic CYP3A4 and CYP1A2 enzymes, potentially increasing bioavailability and plasma concentrations of drugs such as atorvastatin, cyclosporine, amlodipine, and certain antiretrovirals. Anyone taking medications labeled with a grapefruit warning should consult a physician before using Sinetrol.

### Does Sinetrol cause muscle loss while burning fat?

Clinical evidence suggests Sinetrol selectively targets adipose tissue without reducing lean muscle mass. Trials measuring body composition via DEXA or bioelectrical impedance showed fat mass decreased while fat-free mass remained stable or unchanged over 12-week periods. This selectivity is mechanistically plausible because PDE-3 inhibition and HSL activation are predominantly active in lipid-storing adipocytes rather than skeletal muscle fibers.

### What is the difference between Sinetrol and Sinetrol-XPur?

Sinetrol is the original patented extract from Fytexia combining polyphenols from Citrus sinensis (blood orange), Citrus paradisi (grapefruit), and guarana, whereas Sinetrol-XPur is a refined, higher-purity version standardized to a more concentrated polyphenol profile with reduced caffeine contribution. The 2015 French clinical trial used Sinetrol-XPur at 630 mg/day, making XPur the better-evidenced form for fat loss claims. Both versions share the same core PDE-3 inhibition mechanism via naringenin and hesperidin.

### Does Sinetrol work better for certain body types or metabolic conditions?

Clinical trials on Sinetrol have demonstrated efficacy across both Asian and Caucasian populations, suggesting broad applicability across different ethnic groups and likely metabolic profiles. The ingredient's mechanism through PDE-3 inhibition and adipose tissue beiging appears to work independently of baseline body composition, though individual results may vary based on diet, exercise, and genetic factors. Research specifically examining Sinetrol's effectiveness in conditions like metabolic syndrome or insulin resistance remains limited, so consultation with a healthcare provider is recommended for those with specific metabolic concerns.

### What is the mechanism behind Sinetrol's muscle-preserving fat loss effect?

Sinetrol promotes adipose tissue beiging—converting white fat cells to metabolically active brown-like fat—which increases resting energy expenditure without triggering muscle breakdown. The ingredient's 2.8-fold enhancement of lipolysis through PDE-3 inhibition specifically targets fat mobilization rather than protein catabolism, explaining why clinical trials show preservation of lean muscle mass during fat loss. This selective lipolytic effect distinguishes Sinetrol from stimulant-based fat burners that may increase overall metabolic rate indiscriminately.

### Why is Sinetrol-XPur used in clinical research instead of standard Sinetrol?

Sinetrol-XPur represents a purified or optimized form of the original Sinetrol citrus extract, with the 2015 French trial using 630 mg/day of Sinetrol-XPur to achieve significant reductions in waist and hip circumference. The 'XPur' designation likely indicates enhanced extraction, concentration, or standardization of active polyphenolic compounds from Citrus sinensis and Citrus paradisi. This formulation may provide more consistent results and potentially lower required doses compared to earlier versions, making it the preferred choice in recent peer-reviewed research.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*